z-logo
Premium
HIGH‐RISK PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA ARE NOT ENROLLED ON CLINICAL TRIALS
Author(s) -
Reagan P.,
Loh K.P.,
Baran A.,
Hu J.,
Casulo C.,
Barr P.M.,
Friedberg J.W.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2438_42
Subject(s) - medicine , clinical trial , diffuse large b cell lymphoma , progression free survival , oncology , lymphoma , overall survival

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom